MacroGenics, Inc.
MGNX
$3.08
-$0.02-0.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 113.03% | -34.21% | 105.99% | 44.90% | 80.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 113.03% | -34.21% | 105.99% | 44.90% | 80.53% |
| Cost of Revenue | -0.66% | 4.44% | -8.90% | -6.33% | -6.60% |
| Gross Profit | 88.56% | -58.21% | 37.25% | 18.28% | 31.98% |
| SG&A Expenses | -66.79% | -29.77% | -35.51% | -27.13% | 121.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.13% | -4.09% | -14.47% | -11.20% | 20.17% |
| Operating Income | 77.11% | -65.61% | 36.82% | 20.70% | -7.06% |
| Income Before Tax | -3.14% | -70.13% | 35.06% | 21.37% | 68.58% |
| Income Tax Expenses | -182.31% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.21% | -70.13% | 34.88% | 21.37% | 66.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.21% | -70.13% | 34.88% | 21.37% | 66.53% |
| EBIT | 77.11% | -65.61% | 36.82% | 20.70% | -7.06% |
| EBITDA | 79.54% | -63.54% | 38.17% | 21.30% | -7.02% |
| EPS Basic | 8.92% | -70.36% | 35.36% | 22.21% | 66.93% |
| Normalized Basic EPS | 70.79% | -70.35% | 35.55% | 22.23% | -8.81% |
| EPS Diluted | 10.30% | -70.36% | 35.36% | 22.21% | 66.59% |
| Normalized Diluted EPS | 70.79% | -70.33% | 35.55% | 22.23% | -8.81% |
| Average Basic Shares Outstanding | 0.79% | 0.78% | 0.75% | 1.08% | 1.19% |
| Average Diluted Shares Outstanding | 0.79% | 0.66% | 0.75% | 1.08% | 1.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |